Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (521-530 of 993) with videos related to

Pageof 100
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based studyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
The Prostate|February 21, 2018
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasionFelix Preisser, Marco Bandini, Michele Marchioni, et al.
Urologic Oncology|February 11, 2018
External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancerPaolo Dell'Oglio, Marco Bandini, Sami-Ramzi Leyh-Bannurah, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib StudyEdwin M Posadas, Kim N Chi, Ronald de Wit, et al.
Clinical Genitourinary Cancer|April 22, 2019
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial CarcinomaSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
Journal of Surgical Oncology|February 29, 2020
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tractGiuseppe Rosiello, Carlotta Palumbo, Sophie Knipper, et al.
Journal of Surgical Oncology|April 5, 2020
Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decadesGiuseppe Rosiello, Sophie Knipper, Carlotta Palumbo, et al.
European Urology|March 9, 2016
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based StudyPaolo Dell'Oglio, Hiba Abou-Haidar, Sami-Ramzi Leyh-Bannurah, et al.
The Lancet. Oncology|October 17, 2017
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trialTomasz M Beer, Sebastien J Hotte, Fred Saad, et al.
Pageof 100

Showing results (521-530 of 993) with videos related to

Sort By:
Pageof 100
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based studyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
The Prostate|February 21, 2018
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasionFelix Preisser, Marco Bandini, Michele Marchioni, et al.
Urologic Oncology|February 11, 2018
External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancerPaolo Dell'Oglio, Marco Bandini, Sami-Ramzi Leyh-Bannurah, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib StudyEdwin M Posadas, Kim N Chi, Ronald de Wit, et al.
Clinical Genitourinary Cancer|April 22, 2019
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial CarcinomaSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
Journal of Surgical Oncology|February 29, 2020
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tractGiuseppe Rosiello, Carlotta Palumbo, Sophie Knipper, et al.
Journal of Surgical Oncology|April 5, 2020
Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decadesGiuseppe Rosiello, Sophie Knipper, Carlotta Palumbo, et al.
European Urology|March 9, 2016
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based StudyPaolo Dell'Oglio, Hiba Abou-Haidar, Sami-Ramzi Leyh-Bannurah, et al.
The Lancet. Oncology|October 17, 2017
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trialTomasz M Beer, Sebastien J Hotte, Fred Saad, et al.
Pageof 100